URINARY BLADDER NEOPLASMS
Clinical trials for URINARY BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer drug tested in patients who failed standard therapy
Disease control TerminatedThis study tested a new drug called enfortumab vedotin for patients with a type of bladder cancer that hasn't spread into the muscle wall. The drug was delivered directly into the bladder through a thin tube. The main goals were to find a safe dose and see if it could help contro…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Immune-Boosting drug tested to fight recurring bladder cancer
Disease control TerminatedThis study aimed to see if adding an immunotherapy drug called nivolumab to the standard BCG treatment could better control high-risk bladder cancer that had come back or persisted after initial BCG therapy. It was a large Phase 3 trial that was terminated early, enrolling only 1…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC